First Revision of the German S3 Guideline 'Diagnosis, Therapy, and Follow-Up of Breast Cancer'
- PMID: 21373209
- PMCID: PMC2931080
- DOI: 10.1159/000127509
First Revision of the German S3 Guideline 'Diagnosis, Therapy, and Follow-Up of Breast Cancer'
Abstract
The development and implementation of evidence-based, interdisciplinary, consensus-based guidelines is a very important step towards decreasing breast cancer mortality and optimizing the process of early detection, diagnosis, therapy, and follow-up of breast cancer. A revised version of the German S3 guideline was published in February 2008. Different working groups, departments, and organizations participate as coeditors of the new guideline. To fulfill international methodic requirements, a systematic search of the literature with selection of new publications (used as evidence) in the established data bases (Medline, BIOSIS, Previews, CDSR, ACP Journal Club, DARE, CCTR, CINHAL) and the Guidelines International Network (GIN) was performed for the time period of 2003-2006. Varied specialist opinions concerning diagnosis, therapy, and follow-up of breast cancer were considered in formal consensus processes. In different steps, Nominal Group Process techniques, the Delphi technique, and formal consensus processes were used. Besides differently weighted, study-based recommendations, statements resulting from structured consensus finding by the interdisciplinary group - in terms of good clinical practice - were postulated.
Die Entwicklung und Implementierung von evidenz- und konsensusbasierten, interdisziplinären Leitlinien ist ein effektiver Beitrag zur Senkung der Brustkrebsmortalität und Optimierung des Prozesses der Früherkennung, Diagnose, Therapie und Nachsorge beim Mammakarzinom. Eine aktualisierte Version der deutschen S3-Leitllinie wurde im Februar 2008 publiziert. Verschiedene wissenschaftlich-medizinische Fachgesellschaften, Arbeitsgruppen und Organisationen konnten die Überarbeitung realisieren. Um international geforderte methodische Kriterien zu erfüllen, wurde primär eine systematische Lite-raturechereche in etablierten medizinischen Datenbanken (Medline, BIOSIS, Previews, CDSR, ACP Journal Club, DARE, CCTR, CINHAL) und dem Leitlinienregister Guidelines International Network (GIN) veranlasst, um aktuelle und methodisch hochwertige Publikationen als Evidenzgrundlage zu identifizieren. Der Suchzeitraum erstreckte sich von 2003 bis 2006. Das Datenmaterial und die Expertenmeinungen wurden über strukturierte Konsensusprozesse zusammengeführt. Zum Einsatz kamen Techniken des Nominalen Gruppenprozesses (NGP), Delphi-Techniken und formale Konsensusprozesse. So konnten neben studienbasierten Empfehlungen auch Statements im Sinne einer 〈〈good clinical practice〉〉 formuliert werden.
Similar articles
-
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities.Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1089-1109. doi: 10.1055/a-0715-2964. Epub 2018 Nov 26. Geburtshilfe Frauenheilkd. 2018. PMID: 30581199 Free PMC article.
-
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer.Geburtshilfe Frauenheilkd. 2018 Oct;78(10):949-971. doi: 10.1055/a-0713-1218. Epub 2018 Oct 19. Geburtshilfe Frauenheilkd. 2018. PMID: 30364388 Free PMC article.
-
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022) - Part 2 with Recommendations on the Therapy of Precancerous Lesions and Early-stage Endometrial Cancer, Surgical Therapy, Radiotherapy and Drug-based Therapy, Follow-up Care, Recurrence and Metastases, Psycho-oncological Care, Palliative Care, Patient Education, and Rehabilitative and Physiotherapeutic Care.Geburtshilfe Frauenheilkd. 2023 Aug 15;83(8):963-995. doi: 10.1055/a-2066-2068. eCollection 2023 Aug. Geburtshilfe Frauenheilkd. 2023. PMID: 39296646 Free PMC article.
-
Implementation of a Systematic Literature Search Strategy in a National Breast Cancer Guideline: The Relevance of Systemic Therapy in Lymph Node Recurrent Disease.Oncol Res Treat. 2018;41(9):554-559. doi: 10.1159/000490501. Epub 2018 Aug 17. Oncol Res Treat. 2018. PMID: 30114683 Review.
-
The Screening, Diagnosis, Treatment, and Follow-Up of Breast Cancer.Dtsch Arztebl Int. 2018 May 4;115(18):316-323. doi: 10.3238/arztebl.2018.0316. Dtsch Arztebl Int. 2018. PMID: 29807560 Free PMC article.
Cited by
-
Can ki-67 play a role in prediction of breast cancer patients' response to neoadjuvant chemotherapy?Biomed Res Int. 2014;2014:628217. doi: 10.1155/2014/628217. Epub 2014 Mar 25. Biomed Res Int. 2014. PMID: 24783217 Free PMC article.
-
Risk of loco-regional recurrence and distant metastases of patients with invasive breast cancer up to ten years after diagnosis - results from a registry-based study from Germany.BMC Cancer. 2019 May 30;19(1):520. doi: 10.1186/s12885-019-5710-5. BMC Cancer. 2019. PMID: 31146706 Free PMC article.
-
From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prognosis.Microarrays (Basel). 2013 Aug 29;2(3):243-64. doi: 10.3390/microarrays2030243. Microarrays (Basel). 2013. PMID: 27605191 Free PMC article. Review.
-
Quality assessment of HER2 testing by monitoring of positivity rates.Virchows Arch. 2011 Sep;459(3):283-9. doi: 10.1007/s00428-011-1132-8. Epub 2011 Aug 2. Virchows Arch. 2011. PMID: 21809092 Free PMC article.
-
Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques.Br J Cancer. 2015 Dec 1;113(11):1565-70. doi: 10.1038/bjc.2015.381. Epub 2015 Nov 10. Br J Cancer. 2015. PMID: 26554654 Free PMC article.
References
-
- Giersiepen K, Heitmann C, Jahnsen, Lange C. Brustkrebs. In: Robert-Koch-Institut, editor. Gesundheitsberichterstattung des Bundes. Berlin: Robert-Koch-Institut; 2005.
-
- Selbmann HK, Kopp I. Implementierung von Leitlinien in den Versorgungsalltag. Psychiatrie. 2005;1:33–38.
-
- Kreienberg R, Kopp I, members of the guideline group . Interdisziplinäre Leitlinie für die Diagnostik und Therapie des Mammakarzinoms der Frau. München: Zuckschwerdt; 2004.
-
- Lorenz W, Ollenschläger G, Geraedts F, Gerlach F, Gerlach A, Gangjour A, Helou H, Kirchner M, Koller W, Lauterbach H, Reinauer H, Sitter H, Thomeczek C. Das Leitlinien Manual: Entwicklung und Implementierung von Leitlinien in der Medizin. ZaeFQ. 2001;95:1–84.
-
- Scottish Intercollegiate Guidelines Network: SIGN 50: A Guideline Developer's Handbook. Edinburgh, SIGN, 2001. www.sign.ac.uk/guidelines.
LinkOut - more resources
Full Text Sources